Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.53 USD | -15.29% | -13.21% | -25.95% |
May. 10 | Top Midday Decliners | MT |
May. 10 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
Financials (USD)
Sales 2024 * | 1.25B | Sales 2025 * | 1.49B | Capitalization | 2.65B |
---|---|---|---|---|---|
Net income 2024 * | 71M | Net income 2025 * | 99M | EV / Sales 2024 * | 1.9 x |
Net cash position 2024 * | 263M | Net cash position 2025 * | 481M | EV / Sales 2025 * | 1.46 x |
P/E ratio 2024 * |
39.1
x | P/E ratio 2025 * |
27.9
x | Employees | 565 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.32% |
Latest transcript on Progyny, Inc.
1 day | -15.29% | ||
1 week | -13.21% | ||
Current month | -14.13% | ||
1 month | -20.96% | ||
3 months | -31.92% | ||
6 months | -8.78% | ||
Current year | -25.95% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Anevski
CEO | Chief Executive Officer | 56 | 16-12-31 |
Michael Sturmer
PSD | President | 47 | 21-02-28 |
Mark Livingston
DFI | Director of Finance/CFO | 58 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 10-04-30 |
Kevin Gordon
BRD | Director/Board Member | 61 | 19-09-30 |
Norman Payson
BRD | Director/Board Member | 49 | 16-12-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 0 M€ | -.--% | ||
0.10% | 0 M€ | +3.60% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 27.53 | -15.29% | 9,000,761 |
24-05-09 | 32.5 | +1.06% | 1,698,031 |
24-05-08 | 32.16 | -2.72% | 1,145,924 |
24-05-07 | 33.06 | +2.04% | 1,344,482 |
24-05-06 | 32.4 | +2.14% | 763,412 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.95% | 2.65B | |
+14.34% | 125B | |
+16.34% | 98.97B | |
+4.82% | 41.51B | |
-26.70% | 40.44B | |
-1.86% | 20.78B | |
-20.67% | 1.31B | |
-13.87% | 407M |
- Stock Market
- Equities
- PGNY Stock